Earnings NewsHealthcareEgalet Q2 revenues up 18%Aug. 08, 2018 6:46 AM ETZyla Life Sciences (ZCOR) StockBy: SA News Team1 Comment Egalet (EGLT) Q2 results: Revenues: $7.4M (+17.5%). SPRIX Nasal Spray: $5.4M; OXAYDO: $1.7M; ARYMO ER: $0.4M. Net Loss: ($12M) (+54.7%); Loss Per Share: ($0.22) (+78.8%). Recommended For YouRelated StocksSymbolLast Price% ChgZCOR--Zyla Life SciencesTrending AnalysisTrending News